Literature DB >> 7306431

The effect of cimetidine on cyclic nucleotides in human gastric mucosa.

P A Mooney, J M Walters, C F McCarthy, J M O'Donnell.   

Abstract

1 Pre-drug concentrations of both nucleotides were similar in patients with or without peptic ulceration. 2 The effect of a singly infusion or repeated oral administration of cimetidine on human gastric mucosal content of cyclic AMP and cyclic GMP was studied. 3 Biopsies from the body of the stomach were taken at endoscopy from patients who were participating in a clinical trial of the value of cimetidine in the treatment of duodenal ulcer. Cyclic nucleotide determinations and histological examinations were performed on biopsies taken before and after cimetidine treatment. 4 Gastric mucosal content of cyclic AMP was significantly increased (P less than 0.01) 20 min after intravenous infusion of 200 mg cimetidine. There was also a significant increase (P less than 0.01) in gastric mucosal cyclic AMP following administration of the drug orally for 28 days. No alterations in gastric mucosal histology were observed following cimetidine treatment. 5 Gastric mucosal content of cyclic GMP was not altered by intravenous drug infusion, or by chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306431      PMCID: PMC1401858          DOI: 10.1111/j.1365-2125.1981.tb01195.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Analysis of the actions of cimetidine and metiamide on gastric acid secretion in the isolated guinea pig gastric mucosa.

Authors:  S E Sjöstrand; B Ryberg; L Olbe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  Cyclic GMP response in vivo to cholinergic stimulation of gastric mucosa.

Authors:  J H Eichhorn; E W Salzman; W Silen
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

5.  A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique.

Authors:  K C Tovey; K G Oldham; J A Whelan
Journal:  Clin Chim Acta       Date:  1974-11-08       Impact factor: 3.786

6.  Histology of gastric mucosa and its secretory activity in man.

Authors:  V Varró; G Karácsony; E Pach
Journal:  Acta Med Acad Sci Hung       Date:  1973

7.  Stimulation of the gastric mucosa by adenosine-3',5'-monophosphate.

Authors:  J B Harris; D Alonso
Journal:  Fed Proc       Date:  1965 Nov-Dec

8.  Adenyl and guanyl cyclase in rabbit gastric mucosa.

Authors:  C P Sung; B C Jenkins; L R Burns; V Hackney; J G Spenney; G Sachs; V D Wiebelhaus
Journal:  Am J Physiol       Date:  1973-12

9.  Effects of cimetidine on adenylate cyclase activity of guinea pig gastric mucosa stimulated by histamine, sodium fluoride and 5'-guanylylimidodiphosphate.

Authors:  P Anttila; E Westermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-08       Impact factor: 3.000

10.  Stimulation of rat gastric adenylate cyclase by histamine and histamine analogues and blockade by burimamide.

Authors:  J H McNeil; S C Verma
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

View more
  1 in total

1.  Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptic ulcer pathogenesis and selective proximal vagotomy.

Authors:  K P Thon; W Lorenz; C Ohmann; D Weber; H Rohde; H D Röher
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.